Monoclonal antibody BIS-1
Latest Information Update: 03 Apr 2007
Price :
$50 *
At a glance
- Originator University HealthSystem Consortium Services Corporation; University Hospital Groningen
- Class Antineoplastics; Bispecific antibodies; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; CD3 antigen inhibitors; Epithelial cell adhesion molecule inhibitors; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Malignant ascites; Pleural effusion; Renal cancer